Show results for
Refine by
Proficiency Testing Articles & Analysis
3 news found
Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients ...
Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its CLIA certified reference lab. ...
“Clients can be assured of EMSL’s accuracy, as we have proudly passed the CDC Legionella Testing Proficiency Program in our Cinnaminson, NJ; Houston, TX; San Leandro, CA; and Manhattan ...